This interpretation and re-evaluation of the base mechanisms driving somatic mutagenesis is consistent with the original hypothesis that cancer genomes display a “dysregulated AID/APOBEC Ig SHM-like signature” coupled with an ADAR deaminase RNA editing signature and reverse transcription [3,5,7,8,13,14]. Here, AICDA is linked to cancer.